Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
San Gabriel Valley Index
San Gabriel Valley
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Eaton Vance Ohio Municipal Income Trust
(NQ:
EVO
)
5.150
+0.200 (+4.04%)
Streaming Delayed Price
Updated: 1:00 PM EDT, Jul 3, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Eaton Vance Ohio Municipal Income Trust
< Previous
1
2
3
4
Next >
Evotec SE Reports Results for the First Half-year 2023 and Provides Corporate Updates
August 29, 2023
Via
ACCESSWIRE
Evotec SE Reports First Half-Year 2023 Results on 29 August 2023
August 22, 2023
Via
ACCESSWIRE
Evotec Provides Update on Financial Impact of Cyber-Attack
July 27, 2023
Via
ACCESSWIRE
Evotec and Bristol Myers Squibb Enter Licence Agreement within Neuroscience Partnership
July 11, 2023
Via
ACCESSWIRE
Just - Evotec Biologics Awarded Second Contract from U.S. Department of Defense Under Accelerated Antibodies Program
July 05, 2023
Via
ACCESSWIRE
Evotec Receives Milestone Payment for First Patient Dosed in Phase I Study of Bayer Kidney Disease Programme
June 29, 2023
Via
ACCESSWIRE
Evotec SE Provides Update on Cyber Attack
April 10, 2023
Via
ACCESSWIRE
Evotec SE Annual General Meeting 2023 Approves All Proposed Agenda Items
June 20, 2023
Via
ACCESSWIRE
Evotec Presents Sustainability Strategy
June 05, 2023
Via
ACCESSWIRE
Evotec Receives Grant from Open Philanthropy for Discovery of RNA-Targeting Henipavirus Therapeutics
June 02, 2023
Via
ACCESSWIRE
Just - Evotec Biologics Enters Strategic Biosimilars Partnership with Sandoz
May 09, 2023
Via
ACCESSWIRE
Just - Evotec Biologics Launches Tech Partnership for Biosimilars Development and Commercial Manufacturing
May 09, 2023
Via
ACCESSWIRE
Cyber Attack on Evotec
April 07, 2023
Via
ACCESSWIRE
Evotec and Bristol Myers Squibb Extend and Expand Strategic Neurodegeneration Partnership
March 28, 2023
Via
ACCESSWIRE
Evotec SE Preliminary Fiscal Year 2022 Results: 'Ahead of the Curve' - Very Strong Performance in a Challenging Year
March 28, 2023
Via
ACCESSWIRE
Evotec Receives US$ 6.6 m Grant for Drug Discovery in Tuberculosis
March 24, 2023
Via
ACCESSWIRE
Evotec SE to Announce Preliminary Financial Results for Fiscal Year 2022 on 28 March 2023
March 21, 2023
Via
ACCESSWIRE
Evotec Announces Progress in Strategic Protein Degradation Partnership with Bristol Myers Squibb
March 16, 2023
Via
ACCESSWIRE
Sernova Corp. (TSX: SVA) Featured in Coverage of the 35th Annual Roth Conference
February 22, 2023
Via
Investor Brand Network
Evotec Receives € 150 m Loan from European Investment Bank
February 10, 2023
Via
ACCESSWIRE
Evotec and Related Sciences Expand Integrated Drug Discovery and Development Partnership
February 09, 2023
Via
ACCESSWIRE
Evotec SE: Laetitia Rouxel to succeed Enno Spillner as Chief Financial Officer
February 07, 2023
Via
ACCESSWIRE
Evotec Announces Agreement with Janssen to Develop Immune-Based Therapies
January 26, 2023
Via
ACCESSWIRE
Evotec Achieves Further Progress in Neuroscience Collaboration with Bristol Myers Squibb
December 16, 2022
Via
ACCESSWIRE
Evotec SE Reports Results for the First Nine Months 2022 and Provides Corporate Update
November 09, 2022
Via
ACCESSWIRE
Evotec SE to Announce Results for the First Nine Months 2022 on 09 November 2022
November 03, 2022
Via
ACCESSWIRE
Evotec Completes Acquisition of Central Glass Germany
November 03, 2022
Via
ACCESSWIRE
Evotec Presents Paradigm Shift in Biologics at Capital Markets Day
November 02, 2022
Via
ACCESSWIRE
Evotec, CDP Venture Capital and Angelini Ventures Launch Translational Partnership 'Extend' with Leading Italian Academic Institutions
October 28, 2022
Via
ACCESSWIRE
Evotec Enters Partnership with Hannover Medical School to Create Molecular Patient Database in Autoimmune Diseases
October 25, 2022
Via
ACCESSWIRE
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.